Tamim Nazif, MD
Cardiovascular Disease · New York, NYNPI 1942323944
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Edwards Lifesciences at 54.1% of the total. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 495 payments — averaging $327.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$88K
- Boston Scientific$29K
- Biotrace Medical, Inc.$14K
- Baylis Medical Company Inc$9K
- Medtronic$8K
- Shockwave Medical, Inc$4K
- plus $11K from 23 others
Across 152 payments — averaging $13,718 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$1.1M
- Boston Scientific$659K
- Medtronic$259K
- Abbott$36K
What the payments were for
- Consulting fees$76,26347%
- Speaking & faculty fees$16,79910%
- Travel & lodging$52,13732%
- Food & beverage$16,67710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 312 | $87,538 |
| Boston Scientific | 57 | $28,746 |
| Biotrace Medical, Inc. | 3 | $13,600 |
| Baylis Medical Company Inc | 4 | $9,450 |
| Medtronic(2 entities) | 43 | $7,793 |
| Shockwave Medical, Inc | 6 | $3,960 |
| Abbott | 22 | $3,511 |
| Terumo Medical Corporation | 5 | $2,137 |
| Opsens Inc. | 1 | $1,750 |
| Arrow International, Inc. | 2 | $1,332 |
| Teleflex LLC | 3 | $365 |
| Merit Medical Systems Inc | 1 | $325 |
| Siemens Medical Solutions USA, Inc. | 2 | $292 |
| Abiomed | 2 | $178 |
| Boehringer Ingelheim | 10 | $173 |
| Bolton Medical Inc | 1 | $130 |
| Acist Medical Systems, Inc. | 1 | $124 |
| Amgen | 5 | $85 |
| Cardiva Medical, Inc. | 1 | $78 |
| Novartis | 2 | $49 |
| AstraZeneca | 2 | $42 |
| Pfizer | 1 | $38 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Johnson & Johnson | 2 | $31 |
| Heartflow, Inc. | 1 | $24 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$26,277
- GENERAL - STRUCTURAL HEART$9,910
- NRG needle$6,000
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,846
- WATCHMAN Access System$3,273
- VersaCross Access Solution$3,000
- GENERAL - THERAPIES$2,861
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$2,240
- ANGIO-SEAL$2,000
- SavvyWire$1,750
- CoreValve Evolut$1,607
- HeartMate PHP$1,500
- Portico Transcatheter Aortic HV$1,000
- SAPIEN 3 Ultra RESILIA$825
- ISLEEVE$467
- GUIDEWIRES$300
- COREVALVE EVOLUT R$238
- Optis Coronary Imaging System$179
- PASCAL$165
- OPTICROSS$150
How this compares
$161,877 in reported general payments places this provider in the 95th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 16 | $112 |
| Atorvastatin Calcium | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in New York
- Roger HajjarNew York$5.2M
- Gregg StoneNew York$2M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Megha PrasadNew York$813K
- Eyal HerzogNew York$645K
- Nisha JhalaniNew York$443K
- Roxana MehranNew York$432K
- Howard WeintraubNew York$328K
- Anuradha Lala-TrindadeNew York$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.